OpenRegistry
Companies House/London/Company profile

CELEX ONCOLOGY INNOVATIONS LIMITED

Active
11085607·incorporated 2017-11-28

CELEX ONCOLOGY INNOVATIONS LIMITED is an active UK private limited company, incorporated on 28 November 2017 at Companies House (number 11085607; OpenRegistry canonical ID GB-11085607-celex-oncology-innovations-limited). Sophymarine's OpenRegistry classifies it under SIC 21100 (Manufacture of basic pharmaceutical products), one of 1,198 active UK entities in that code and one of 1,094,587 active companies registered in London (postcode W1W). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2017-11-28
Registered Address
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, W1W 6XH, UNITED KINGDOM
SIC
21100 — Manufacture of basic pharmaceutical products
Country of origin
United Kingdom

Directors

Search directors of CELEX ONCOLOGY INNOVATIONS LIMITED

Shareholders

Look up shareholders of CELEX ONCOLOGY INNOVATIONS LIMITED

Financials

Check financials of CELEX ONCOLOGY INNOVATIONS LIMITED

Filings

Check filing history of CELEX ONCOLOGY INNOVATIONS LIMITED

Accounts

Last filed accounts made up to 2024-12-31. Next accounts due 2026-09-30. Financial year-end: 31/12. Filing class: TOTAL EXEMPTION FULL.

Confirmation statement

Last confirmation statement made up to 2025-04-05. Next confirmation statement due 2026-04-19.

Mortgages and charges

1 charge recorded against the company at Companies House: 1 outstanding, 0 satisfied, 0 partially satisfied.

Persons with significant control

  • No individual or entity with significant control has been identified.

3 historical PSC records have ceased:

  • Dr Vasileios Xeniades born 1965 resident in Greece, Greek national. Notified 2019-09-25. Ceased 2020-06-08.
    • Has significant influence or control
  • Mr Laurence John Cohen born 1951 resident in United Kingdom, United Kingdom national. Notified 2017-11-28. Ceased 2019-09-25.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Professor Mustafa Bilgin Ali Djamgoz born 1952 resident in United Kingdom, British national. Notified 2017-11-28. Ceased 2024-11-21.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights

Similar UK companies

Other companies registered under SIC 21100 (Manufacture of basic pharmaceutical products):

Other companies registered in London:

Need real-time profile, officers, shareholders, financials or filing? Open the live profile at /company/gb/11085607.

Source: Companies House Free Company Data, refreshed 2026-06-06. Official record: find-and-update.company-information.service.gov.uk.